Wealthcare Capital Management’s Cytosorbents CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-463
Closed -$122K – 490
2015
Q1
$122K Buy
+463
New +$95.3K 0.01% 136

Other funds holding CTSO

Wealthcare Capital Management's CTSO Position: Q2 2015 in Review

Wealthcare Capital Management sold out of Cytosorbents (CTSO) in Q2 2015, closing a stake of 463 shares — an estimated $122K sold.

Wealthcare Capital Management first reported a position in CTSO in Q1 2015 and held it in 1 quarter. The position peaked at $122K in Q1 2015. 31 funds tracked by Wall St. Rank hold CTSO as of Q2 2015.

  • Wealthcare Capital Management reported no remaining Cytosorbents position as of Q2 2015 after selling out during the quarter.
  • Wealthcare Capital Management sold 463 Cytosorbents shares in Q2 2015, an estimated $122K.
  • Wealthcare Capital Management first reported a position in Cytosorbents in Q1 2015 and held it in 1 quarter.
  • Wealthcare Capital Management's Cytosorbents position peaked at $122K in Q1 2015.
  • 31 funds tracked by Wall St. Rank held Cytosorbents as of Q2 2015.

Based on Wealthcare Capital Management's 13F filing for Q2 2015, filed 24 Aug 2015.